Welcome News:
One Nucleus welcomes the Government's support of Cambridge to continue developing as a destination to attract global investment and talent in life sciences through plans to create aspirational housing and communities for those employed in the sector.
Housing to Match Aspiration:
The focus on home ownership whilst important may not in itself deliver the correct balance of residential accommodation. In innovation-driven industries such as ours, a significant proportion of the workforce are international, many of whom seeing the attraction of Cambridge as the next step, but perhaps…
Having recently attended the London Stem Cell Conference, Oliver Herd, a trainee patent attorney at IP law firm Appleyard Lees IP LLP, reflects on some of the current activity in the stem cell field and how products, methods and consumables can be protected in Europe.
On 27 June 2023, Magdalena Zernicka-Goetz was awarded the Ogawa-Yamanaka Stem Cell prize for her work in determining the mechanisms that drive mammalian embryo development through the creation of in vitro 3D models. These models, which develop brain structures and a beating heart, appeared in Nature’s list of “Seven…
BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will highlight the integral role it is playing in liquid biopsy research at the American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. This conference will be held from July 23-27 at the Anaheim Convention Center in Anaheim, CA.
“Liquid biopsy research can revolutionize the…
The Health Systems Task Force is a public-private strategic partnership, bought together by Sir Pascal Soriot, CEO of Astrazenca, which gathers other CEOs and leaders from key stakeholders such as:
GSK
Merck KGaA
Novo Nordisk
Roche
Samsung Biologicals
Sanofi
Karolinska Instituet
National Health Service England
the Sustainable Healthcare Coalition
UNICEF
The University of Pavia
World Health Organizaton (WHO)
The purpose of The Health Systems Task Force is to take joint, scaleable action to help accelerate the delivery of net zero healthcare.
Find out…
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in Japan
Lean, go-to-market commercial model, well positioned to scale rapidly to generate significant value from Japan and APAC (ex-China) geographic expansion
Includes Japan and APAC (ex-China) rights1 to two life-changing medicines with significant growth potential:
PIVLAZ® (clazosentan;…
The results from Eli Lilly's Phase 3 trial of Donanemab showed that the drug significantly slowed cogntive and functional decline for early symptomatic Alzheimer's disease patients, decreasing their risk of disease progression. Their recent press release stated that "nearly half of participants at earlier stage of disease on donanemab had no clinical progression at 1 year".
This study demonstrates the importance of an early diagnosis and brings hope to people with Alzheimer's disease.
Read the full press release.
Are you a vegan or vegetarian woman, at least 18 years old, live within 40 miles of Norwich and in good health?
The Quadram institute are conducting a 17-week study to investigate the use of hydroponically-grown, biofertified salad greens, and use of a dietary app, on iron and B12 status in vegan or vegetarian women of child-bearing age.
Interested in taking part? Find out more information and how to register your interest here.
PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced today that it has acquired PrecisionMed, LLC, a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.
Based in Carlsbad, CA, PrecisionMed has been collecting biospecimens for neurology and oncology research for more than 27 years…
Oxford, UK, 18 July 2023 – PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients.
Long COVID is a debilitating chronic condition that has…
CAMBRIDGE, England & BOSTON, Jun. 23, 2023-- Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of
Alethia Young as its new Chief Financial Officer, effective July 17th.
Ms. Young joins Bicycle from Graphite Bio, where she served as Chief Financial Officer, and previously served as senior biotech analyst and head of research at Cantor Fitzgerald.
“We are…